Published by Lawsuits are now available for individuals who were diagnosed with pancreatic cancer or bullous pemphigoid after taking Jentadueto, a type 2 diabetes medication.
Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with pancreatic cancer after using Jentadueto, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
FDA Investigating Link Between DPP-4 Inhibitors & Rhabdomyolysis
December 1, 2017 - FDA has received reports of rhabdomyolysis [1], a syndrome caused by injury to skeletal muscle, in patients with type 2 diabetes who have taken Jantadueto and other DPP-4 inhibitors. The agency has not yet offered any formal recommendations, and patients should talk to their doctor before switching medications or discontinuing use.
What’s the Problem?
The potential side effects of incretin mimetic drugs like Jentadueto have recently become a subject of serious concern among individuals with type 2 diabetes. These concerns came in response to several studies which identified a casual link between incretin mimetics and cancer of the pancreas and thyroid. According to a study published in the medical journal Gastroenterology [2], the use of Byetta (another incretin mimetic in the same class as Jentadueto) increased the risk of pancreatitis by six times compared to other types of diabetes drugs.
If left untreated, pancreatitis has the potential to lead to full-blown pancreatic cancer. The study also raised caution about the drugs’ ability to cause thyroid cancer. If you or a loved one has developed cancer after using Jentadueto, you may qualify to participate in a Jentadueto Lawsuit.
Jentadueto and Pancreatic Cancer
Pancreatic cancer originates in the pancreas, a large organ that manufactures enzymes that help digest food. The disease occurs when cells grow abnormally in the pancreas, and multiply to form tumors that can affect the ability of the organ to function properly.
In the initial stages of pancreatic cancer, a tumor may develop without symptoms, which means that the disease is often terminal when it is finally identified. Jentadueto pancreatic cancer symptoms may include:
- dark urine
- clay-colored stools
- fatigue
- weakness
- jaundice
- loss of appetite
- weight loss
- nausea
- vomiting
- pain or discomfort in the upper part of the belly or abdomen
- back pain
- blood clots
- diarrhea
- indigestion
Bullous Pemphigoid
A rare skin disease called bullous pemphigoid that causes severe skin blistering has been linked to Jentadueto and all other diabetes drugs from the DPP-4 inhibitor class. In October 2016, FDA asked manufacturers of DPP-4 inhibitors to add a bullous pemphigoid warning to their products' labeling after the agency received multiple reports of the condition associated with the drugs. Each case had severe health outcomes, half of them required hospitalization and one died.
Thyroid Cancer
Thyroid cancer was first linked to incretin mimetic diabetes drugs by an animal study which found an association between the disease and Victoza. The FDA required that a black box warning be placed on Victoza labels, and many have expressed concerns that the same warning should be placed on all other incretin mimetic labels as well.
Signs and symptoms of Jentadueto thyroid cancer may include:
- lumps / nodules in the neck
- hoarseness / changes to the voice
- swallowing or breathing problems
- pain in the throat / neck
- swollen lymph nodes in the neck
- cough not caused by other conditions
- enlarged thyroid gland
Related Articles:
Which Diabetes Drugs are Incretin Mimetics?
In addition to Jentadueto, other incretin mimetics include:
- Byetta (exenatide)
- Bydureon (exenatide)
- Janumet (metformin and sitagliptin)
- Janumet XR (sitagliptin and metformin HCl extended-release) [3]
- Januvia (sitagliptin)
- Kazano (alogliptin and metformin)
- Kombiglyze XR (saxagliptin and metformin)
- Nesina (alogliptin)
- Onglyza (saxagliptin)
- Oseni (alogliptin and pioglitazone)
- Tradjenta (linagliptin)
- Victoza (liraglutide)
See all dangerous drugs lawsuits we've taken on.
Do I have a Jentadueto Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Jentadueto lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Free Confidential Case Evaluation: Again, if you got pancreatic cancer after taking Jentadueto, you should contact our law firm immediately. You may be entitled to compensation by filing a class action suit and our lawyers can help.
To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: 